OpenURL Connection Search

Select item for more details and to access through your institution.

Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.
Published in:
2019
By:
- Susanna Meijer, T.;
- Geus-Oei, Lioe-Fee de;
- Martini, Christian H.;
- Tijl, Fred G. J.;
- Elske Sitsen, M.;
- van Erkel, Arian R.;
- van der Meer, Rutger W.;
- Kapiteijn, Ellen;
- Vahrmeijer, Alexander L.;
- Burgmans, Mark C.;
- Meijer, T Susanna;
- Sitsen, M Elske;
- Erkel, Arian R van;
- Meer, Rutger W van der
Publication type:
journal article
Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 2, p. 1130, doi. 10.1245/s10434-020-08741-x
By:
- Meijer, T. Susanna;
- Burgmans, Mark C.;
- de Leede, Eleonora M.;
- de Geus-Oei, Lioe-Fee;
- Boekestijn, Bas;
- Handgraaf, Henricus J. M.;
- Hilling, Denise E.;
- Lutjeboer, Jacob;
- Vuijk, Jaap;
- Martini, Christian H.;
- van Erkel, Arian R.;
- van der Meer, Rutger W.;
- Tijl, Fred G. J.;
- Speetjens, Frank M.;
- Kapiteijn, Ellen;
- Vahrmeijer, Alexander L.
Publication type:
Article
ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 3, p. 820, doi. 10.1245/s10434-020-08806-x
By:
- Meijer, T. Susanna;
- Burgmans, Mark C.
Publication type:
Article
Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial.
Published in:
2019
By:
- Meijer, T. Susanna;
- Burgmans, Mark C.;
- Fiocco, Marta;
- de Geus-Oei, Lioe-Fee;
- Kapiteijn, Ellen;
- de Leede, Eleonora M.;
- Martini, Christian H.;
- van der Meer, Rutger W.;
- Tijl, Fred G. J.;
- Vahrmeijer, Alexander L.
Publication type:
journal article
Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
Published in:
2017
By:
- Leede, Eleonora;
- Burgmans, Mark;
- Meijer, T.;
- Martini, Christian;
- Tijl, Fred;
- Vuyk, Jaap;
- Erkel, Arian;
- Velde, Cornelis;
- Kapiteijn, Ellen;
- Vahrmeijer, Alexander;
- de Leede, Eleonora M;
- Burgmans, Mark C;
- Meijer, T Susanna;
- Martini, Christian H;
- Tijl, Fred G J;
- van Erkel, Arian R;
- van der Velde, Cornelis J H;
- Vahrmeijer, Alexander L
Publication type:
journal article
Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
Published in:
2017
By:
- Leede, Eleonora;
- Burgmans, Mark;
- Meijer, T.;
- Martini, Christian;
- Tijl, Fred;
- Vuyk, Jaap;
- Erkel, Arian;
- Velde, Cornelis;
- Kapiteijn, Ellen;
- Vahrmeijer, Alexander;
- de Leede, Eleonora M;
- Burgmans, Mark C;
- Meijer, T Susanna;
- Martini, Christian H;
- Tijl, Fred G J;
- van Erkel, Arian R;
- van der Velde, Cornelis J H;
- Vahrmeijer, Alexander L
Publication type:
journal article
Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.
Published in:
PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0261939
By:
- Meijer, T. Susanna;
- Dieters, Jan H. N.;
- de Leede, Eleonora M.;
- de Geus-Oei, Lioe-Fee;
- Vuijk, Jaap;
- Martini, Christian H.;
- van Erkel, Arian R.;
- Lutjeboer, Jacob;
- van der Meer, Rutger W.;
- Tijl, Fred G. J.;
- Kapiteijn, Ellen;
- Vahrmeijer, Alexander L.;
- Burgmans, Mark C.
Publication type:
Article

Found: 7

Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.

Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.

ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma.

Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial.

Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.

Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.

Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.